Phenomix Sciences
About this raise
Only 30% of patients respond well to a given obesity treatment, but typical treatment is ad hoc, wasting precious time and money. As Mayo Clinic obesity doctors, we've demonstrated that identifying a patient's specific type (aka phenotype) of obesity and personalizing their treatment produces twice the amount of weight loss. With exclusive tech from Mayo Clinic, we are commercializing our first product in the form of a simple blood test to bring forward precision medicine to weight-loss therapy.
Investment Overview
Invested : $340,268
Deal Terms
Total Commitments
- Platform
- Wefunder
- Start Date
- 11/29/2018
- Close Date
- 03/15/2019
$200,000
$1,070,000
$100
Convertible Note
RegCF
$9,600,000
0%
Company & Team
Company
- Year Founded
- 2017
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B2C
- Margin
- Capital Intensity
- Location
- Rochester, Minnesota
- Company Website
-
Visit Website
Team
- Employees
- 1
Financials
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 03/15/2019 | Wefunder | $9,600,000 | $340,268 | Convertible Note | Funded | RegCF |